Elevance Health (NYSE:ELV) Given New $480.00 Price Target at Truist Financial

Elevance Health (NYSE:ELV – Get Free Report) had its price objective cut by research analysts at Truist Financial from $520.00 to $480.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Truist Financial’s price target would indicate a potential upside of 26.16% from the […]

Leave a Reply

Your email address will not be published.

Previous post GoDaddy Inc. (NYSE:GDDY) CFO Mark Mccaffrey Sells 5,500 Shares
Next post Barclays Upgrades Synchrony Financial (NYSE:SYF) to Overweight